<DOC>
	<DOCNO>NCT00273507</DOCNO>
	<brief_summary>Randomised trial chemotherapy surgery early resectable stage NSCLC ( IB , IIA , IIB , IIIA/N2 ) .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy Non Small Cell Lung Cancer ( NSCLC ) Stages IB , IIA , IIB , IIIA/T3</brief_title>
	<detailed_description>Randomisation 3 course neoadjuvant Carboplatin plus Paclitaxel chemotherapy surgery .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>NSCLC Stages IB , IIA , IIB , IIIA/T3 Lung function test allow surgery Age 1875 year Poor lung function Performance status 34 Mediastinal lymph node involvement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>neoadjuvant</keyword>
	<keyword>resection</keyword>
</DOC>